The present work describes the construction and validation of a human scFv library with a novel design approach to synthetic complementarity determining region (CDR) diversification. The advantage of synthetic antibody libraries includes the possibility of exerting fine control over factors like framework sequences， amino acid and codon usage， and CDR diversity. However， random combinatorial synthesis of oligonucleotides for CDR sequence diversity also produces many clones with unnatural sequences and/or undesirable modification motifs. To alleviate these issues， we designed and constructed a novel semi-synthetic human scFv library with non-combinatorial， pre-designed CDR diversity and a single native... More
The present work describes the construction and validation of a human scFv library with a novel design approach to synthetic complementarity determining region (CDR) diversification. The advantage of synthetic antibody libraries includes the possibility of exerting fine control over factors like framework sequences， amino acid and codon usage， and CDR diversity. However， random combinatorial synthesis of oligonucleotides for CDR sequence diversity also produces many clones with unnatural sequences and/or undesirable modification motifs. To alleviate these issues， we designed and constructed a novel semi-synthetic human scFv library with non-combinatorial， pre-designed CDR diversity and a single native human framework each for heavy， kappa， and lambda chain variable domains. Next-generation sequencing analysis indicated that the library consists of antibody clones with highly nature-like CDR sequences and the occurrence of the post-translational modification motifs is minimized. Multiple unique clones with nanomolar affinity could be isolated from the library against a number of target antigens， validating the library design strategy. The results demonstrate that it is possible to construct a functional antibody library using low， non-combinatorial synthetic CDR diversity， and provides a new strategy for the design of antibody libraries suitable for demanding applications.
